ARTICLE | Company News
Suzhou NeuPharma, Coronado Biosciences deal
April 13, 2015 7:00 AM UTC
NeuPharma granted Coronado exclusive rights to develop and commercialize irreversible EGFR inhibitors outside undisclosed Asian countries. NeuPharma will receive an upfront payment and is eligible fo...